NAGE - NASDAQ

NB

Niagen Bioscience Inc

NAGE·NASDAQ

$3.46

-2.1%
HealthcareBiotechnology

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$275.97M
EPS0.2200
P/E Ratio15.75
Earnings Date08/05/2026
15.61%
Return on Invested Capital
7%
3Y-131.0%
5Y-118.0%
10Y-160.0%
22.71%
Return on Equity
22%
3Y-139.0%
5Y-119.0%
10Y-177.0%
16.34%
Return on Assets
30%
3Y-153.0%
5Y-131.0%
10Y-210.0%
NB

Niagen Bioscience Inc Management Team

NAGE · NASDAQ
MR

Mr. Robert N. Fried

Chief Executive Officer & Director

Compensation

$787,233

Born 1960(Age 66)
male
MO

Mr. Ozan Pamir C.F.A.

Chief Financial Officer & Principal Accounting Officer

Compensation

$387,481

Born 1992(Age 34)
male
MM

Ms. Michiko Kelley

Chief Marketing Officer

female
MF

Mr. Frank Louis Jaksch Jr.

Co-Founder & Chairman

Compensation

$70,000

Born 1968(Age 58)
male
MJ

Mr. James Lee

Controller

Compensation

$286,491

Born 1976(Age 50)
male
KK

Kendall Knysch

Head of Media Relations & Partnerships

MC

Ms. Chu Yan

Managing Director of Asia Pacific

female
MC

Mr. Carlos Lopez

Senior Vice President & General Counsel

Compensation

$357,754

male
DA

Dr. Andrew Shao Ph.D.

Senior Vice President of Global Regulatory & Scientific Affairs

n

Niagen Bioscience Inc Insider Positioning

NAGE · NASDAQ

During the last 12 months, insiders have purchased $2.01M worth of NAGE shares, with no selling activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

4.5K

30.40K

Sold

0

0.00

Net Activity

+30K

+$30K

9-12 Months

Bought

140.0K

1.98M

Sold

0

0.00

Net Activity

+2.0M

+$1.98M

Top Buyers

1
YWTW

Yu Wing Tak Wendy

Director

20.0K shares•1 transactions

$283K

2
PK

Patrick Kristin

Director

20.0K shares•1 transactions

$283K

3
RSD

Rubin Steven D

Director

20.0K shares•1 transactions

$283K

4
SH

Shahbazi Hamed

Director

20.0K shares•1 transactions

$283K

5
CA

Cohen Ann

Director

20.0K shares•1 transactions

$283K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $2.01M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

∞:1

Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.

Insider Participation

High Buying

5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.

SEC Filings

NAGE - Filing history and reports

No SEC filings available for NAGE

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.